Anika Therapeutics, Inc. (ANIK) ownership: Top institutional holder: BlackRock Fund Advisors ($57.46M). Insider activity: Net Seller (4 buys, 16 sells). 8 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock Fund Advisors | 1173660.00 | $57.46M | 2016-12-31 |
| BlackRock, Inc. | 1594893.00 | $23.13M | 2026-03-31 |
| Caligan Partners LP | 1435130.00 | $20.81M | 2026-03-31 |
| MORGAN STANLEY | 872066.00 | $12.64M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 606544.00 | $8.79M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 605777.00 | $8.78M | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 529503.00 | $7.68M | 2026-03-31 |
| VANGUARD GROUP INC | 779165.00 | $7.49M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-05-01 | |
| Buy | null | 2026-05-01 | |
| Buy | null | 2026-04-30 | |
| Sell | null | 2026-04-30 | |
| Sell | null | 2026-03-19 |
Back to ANIK overview · ANIK earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.